SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-275175
Filing Date
2021-09-16
Accepted
2021-09-16 16:33:02
Documents
22
Period of Report
2021-09-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d227179d8k.htm   iXBRL 8-K 29025
2 EX-10.1 d227179dex101.htm EX-10.1 56663
6 GRAPHIC g227179g07a01.jpg GRAPHIC 7626
7 GRAPHIC g227179g07a02.jpg GRAPHIC 6370
8 GRAPHIC g227179g07b03.jpg GRAPHIC 6035
9 GRAPHIC g227179g07b04.jpg GRAPHIC 10353
10 GRAPHIC g227179g09a01.jpg GRAPHIC 7286
11 GRAPHIC g227179g09b02.jpg GRAPHIC 6289
12 GRAPHIC g227179g09c03.jpg GRAPHIC 5875
13 GRAPHIC g227179g09d04.jpg GRAPHIC 11303
14 GRAPHIC g227179g37n77.jpg GRAPHIC 4012
  Complete submission text file 0001193125-21-275175.txt   314615

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA krys-20210913.xsd EX-101.SCH 2898
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE krys-20210913_lab.xml EX-101.LAB 18888
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE krys-20210913_pre.xml EX-101.PRE 11864
15 EXTRACTED XBRL INSTANCE DOCUMENT d227179d8k_htm.xml XML 3495
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Filer) CIK: 0001711279 (see all company filings)

IRS No.: 821080209 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38210 | Film No.: 211258320
SIC: 2836 Biological Products, (No Diagnostic Substances)